FibroGen’s $150 Million Financing with Morgan Stanley Tactical Value

Goodwin Procter acted as counsel to FibroGen, and Gibson Dunn acted as counsel to Morgan Stanley Tactical Value.FibroGen, Inc. (NASDAQ: FGEN) announced a non-dilutive term loan…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

This content is for Standard 1 Year members only.
Login Join Now